Cas 501423-60-5,1H-Pyrazole-3-carboxylic acid, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-, ethyl ester

501423-60-5

Post Buying Request

Basic information

Product Name: 1H-Pyrazole-3-carboxylic acid, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-, ethyl ester
Synonyms:
CAS NO:501423-60-5
Molecular Formula: C19H15BrCl2N2O3
Molecular Weight: 470.15
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1H-Pyrazole-3-carboxylic acid, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-, ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 1H-Pyrazole-3-carboxylic acid, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-, ethyl ester(501423-60-5)
EPA Substance Registry System: 1H-Pyrazole-3-carboxylic acid, 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-, ethyl ester(501423-60-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 501423-60-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

501423-60-5 Suppliers

Recommended suppliers

501423-60-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 501423-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,4,2 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 501423-60:
(8*5)+(7*0)+(6*1)+(5*4)+(4*2)+(3*3)+(2*6)+(1*0)=95
95 % 10 = 5
So 501423-60-5 is a valid CAS Registry Number.

501423-60-5Upstream product

288104-76-7 ethyl 4-(bromomethyl)-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-pyrazole-3-carboxylate

501423-60-5Downstream Products

501423-60-5Relevant academic research and scientific papers

Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands

Lee, Suk Ho,Seo, Hee Jeong,Kim, Min Ju,Kang, Suk Youn,Song, Kwang-Seop,Lee, Sung-Han,Jung, Myung Eun,Kim, Jeongmin,Lee, Jinhwa

scheme or table, p. 1899 - 1902 (2009/11/30)

Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 501423-60-5